TABLE 1.
Primer names and sequences.
Primer name | Amplification efficiency (%) | Sequence (5′to 3′) | Amplicon sizeL (bp) |
---|---|---|---|
qPCR -FST F | 92.3 | ACTCGGACTACACGGCCTAT | 77 |
qPCR -FST R | 92.3 | AGAACTGTCCCCGTATTGCG | 77 |
qPCR -MSTN F | 94.9 | CGGACAAGATGCCTGTGAGT | 88 |
qPCR -MSTN R | 94.9 | TGTGTGTCCTGTTCACCGAG | 88 |
qPCR- APOA1 F | 93.5 | GGATCTGCGCACCTCTATCC | 101 |
qPCR- APOA1 R | 93.5 | GGATCTGCGCACCTCTATCC | 101 |
qPCR-ghra F | 94.1 | AGCCAGAGCGTAGCAAACTT | 156 |
qPCR-ghra R | 94.1 | GTTGGGGGTGAGTAAGAGGC | 156 |
qPCR-AKT F | 93.5 | CCGAGATTGTCTCCGCTCTC | 170 |
qPCR-AKT R | 93.5 | GGACACCACTTGGTCTCTCG | 170 |
qPCR-Keap1 F | 94.2 | CGTGGGTGTAGCCATTACCA | 144 |
qPCR-Keap1R | 94.2 | TGACTGTGCTGCTGACTCTG | 144 |
qPCR-Nrf2 F | 92.6 | GCCAATCACTAATGCGGCAG | 80 |
qPCR-Nrf2 R | 92.6 | GCCACTGTTGTAGCCACTCT | 80 |
qPCR-Myf5 F | 92.7 | AGGGACTCCTCTCGTGCATT | 146 |
qPCR-Myf5 R | 92.7 | CTCCATGCCAGGACCAAAGT | 146 |
qPCR-MyoD1 F | 92.3 | ACGCCATCAGCTACATCGAG | 157 |
qPCR-MyoD1 R | 92.3 | GTAACAGGTGTCCGCTCACT | 157 |
qPCR-MyoG F | 95.1 | GGTGTCCTCCCTAAACCAGC | 130 |
qPCR-MyoG R | 95.1 | CCGAACTAGGCTCACTCGAC | 130 |
qPCR-TGF-β1 F | 95.0 | GTGGGGAAATCTGCCCGTTA | 147 |
qPCR-TGF-β1 R | 95.0 | CAGCCGAAGTTGGAAGACCT | 147 |
Beta-actin F | 92.2 | CTCTTCCAGCCATCCTTCCT | 220 |
Beta-actin R | 92.2 | TCAGGTGGGGCAATGATCTT | 220 |
5′RACE-FST F1 | — | TTGCCAGCTTGAACTT | - |
5′RACE-FST F2 | — | TGATGTTCCATAAGGTGA | — |
5′RACE-FST F3 | — | AATGCCCGGGTGGAGGTG | — |
3′RACE-FST R1 | — | GTCCAGAGAGCCGAACAGATGAGG | — |
3′RACE-FST R2 | — | GCGTGTTCAATGGGAGTTCTGCTG | — |
5′RACE-MSTN F1 | — | GCAGGAACACCGTGGT | — |
5′RACE-MSTN F2 | — | GCAGGTGAACCCACAGCT | — |
5′RACE-MSTN F3 | — | TTGACTCGGCTGGAACTT | — |
3′RACE-MSTN R1 | — | AGCGTTACAAGGCCAACTACTGCT | — |
3′RACE-MSTN R2 | — | TGCAGAAGTACCCACACACTCACC | — |